Transforming growth factor-β1 contributes to oxaliplatin resistance in colorectal cancer via epithelial to mesenchymal transition.

Oncol Lett · 2017 · PMC5494727 · PMID 28693217

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a marked trendno p-value reported

4 , there was a marked trend that demonstrated that 3 and 5 ng/ml TGF-β1 exerted more powerful anti-apoptotic effects compared with untreated cells.

also in 422 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.